The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 08, 2023

Filed:

May. 24, 2021
Applicant:

Keros Therapeutics, Inc., Lexington, MA (US);

Inventors:

Jasbir S. Seehra, Lexington, MA (US);

Jennifer Lachey, Lincoln, MA (US);

Assignee:

Keros Therapeutics, Inc., Lexington, MA (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07H 21/04 (2006.01); C12N 15/86 (2006.01); C07K 14/71 (2006.01); A61K 38/18 (2006.01); A61K 47/65 (2017.01); A61P 19/08 (2006.01); C07K 14/76 (2006.01); C12N 15/85 (2006.01); C12P 21/02 (2006.01); A61K 38/00 (2006.01); A61K 47/64 (2017.01);
U.S. Cl.
CPC ...
A61K 38/18 (2013.01); A61K 47/65 (2017.08); A61P 19/08 (2018.01); C07K 14/71 (2013.01); C07K 14/76 (2013.01); C12N 15/85 (2013.01); C12P 21/02 (2013.01); A61K 38/00 (2013.01); A61K 47/64 (2017.08);
Abstract

The invention features polypeptides that include an extracellular ActRIIa variant. In some embodiments, a polypeptide of the invention includes an extracellular ActRIIa variant fused to an Fc domain monomer or moiety. The invention also features pharmaceutical compositions and methods of using the polypeptides to treat diseases and conditions involving weakness and atrophy of muscles, e.g., Duchenne muscular dystrophy, facioscapulohumeral muscular dystrophy, inclusion body myositis, amyotrophic lateral sclerosis, sarcopenia; or cancer cachexia; or metabolic diseases, e.g., obesity, Type-1 diabetes, or Type-2 diabetes.


Find Patent Forward Citations

Loading…